Connect with us

Cannabis News

Ohio Attorney General Approves Referendum To Reverse Marijuana And Hemp Restrictions

Published

on

Ohio’s attorney general has accepted a recent submission a referendum petition to block parts of a restrictive marijuana and hemp law He said it was “misleading” to go into effect after rejecting an initial version.

“After careful review of this submission, I conclude that the title and summary are a fair and true statement of the proposed measure,” Attorney General Dave Yost (R) wrote in a letter to the petitioners on Wednesday.

“My certification of the title and abstract … should not be construed as an endorsement of the enforceability and constitutionality of the referendum petition,” he said. “My role, as executed here, is to determine whether the wording of the title and summary adequately advises the material components of a measure.”

The Ohioan-led referendum for Cannabis Choice wants it that way repealing key components of the bill the governor recently signed it Reduce the state’s voter-approved marijuana law and prohibit the sale of consumable hemp products outside of licensed cannabis dispensaries.

Yost said last month that an initial submission from the group contained “omissions and errors that would generally mislead a potential signer about the scope and effects of SB 56.” Then they presented an updated version.

Now the latest version of the band the proposal it has been accepted attorney general, efforts can begin to collect a total of around 250,000 signatures for the vote.

The office of Gov. Mike DeWine (R) and a senator who led the charge to pass SB 56 have had it He criticized the cannabis referendum campaign.

In essence, the proposed referendum would repeal the first three sections of the controversial bill DeWine signed into law in December, which he says is intended to combat the unregulated intoxicating hemp market. But the legislation would do more than limit the sale of cannabinoid products to dispensaries.

The law also criminalizes certain marijuana activities that were legalized under the 2023 ballot initiative, and would also remove anti-discrimination protections for cannabis users that were established under that law.

The governor also used his line veto powers to cancel a section of the bill that would have delayed the implementation of the hemp beverage ban.

Advocates and stakeholders vehemently protested the current legislation, arguing that it undermines the will of voters who approved cannabis legalization and would effectively wipe out the state’s hemp industry, as there is little hope that adults will choose hemp-based products over marijuana when they visit a dispensary.

The rejection spurred the newly introduced referendum, but the road to successfully blocking the law is narrow.

If activists reach the signature threshold by the deadline, which coincides with the same day the restrictive law goes into effect, SB 56 would not be enacted until voters have a chance to decide on the issue on the ballot.

A summary of the submitted referendum reads: “Sections 1, 2, and 3 of 56 Am. Sub. Sub. SB enact new provisions and amend and repeal existing provisions in the Ohio Revised Code relating to the regulation, criminalization, and taxation of cannabis products, such as the sale, use, possession, cultivation, licensing, classification, classification of marijuana, marijuana, and certain hemp products.”

“If the majority of voters vote not to approve Articles 1, 2 and 3 of the Act, the approved amendments will not have any effect and the previous version of the affected laws will remain in force,” it says.

Advocates have expressed several concerns with the law, including that it would eliminate language in statutes that provide anti-discrimination protections to people who legally use cannabis. It includes safeguards against adverse action in the context of child custody rights, the ability to perform organ transplants, and professional licensing.

It would also recriminalize possession of marijuana from any source other than a state-licensed Ohio dispensary or possession of marijuana from a legal household. Because of this, people can be charged with a felony for carrying cannabis purchased from a legal Michigan store in the Michigan area.

It would also ban the smoking of cannabis in outdoor public places, such as bar patios, and ban landlords from vaping marijuana in rental properties. Violation of this latter policy, even if it involves vaping in a person’s backyard in a rental property, would be a misdemeanor offense.

The legislation would also replace what had been a regulatory framework for intoxicating hemp that the House passed with a broad ban on over-the-counter marijuana sales, following a recent federal move to recriminalize such products.

By law, hemp items containing more than 0.4 mg of total THC per container or containing synthetic cannabinoids cannot be sold outside of a licensed marijuana dispensary. That would be in line with the new federal hemp law included in an appropriations package signed by President Donald Trump.

The federal law banning most consumer hemp products has a one-year implementation window, however, and Ohio’s legislation appears likely to go into effect sooner. The Legislature approved a temporary hemp beverage regulatory program in Ohio until December 31, 2026, but the governor vetoed that provision.

The law also includes language that, if the federal government moves to legalize hemp with a higher THC content, the Ohio legislature intends to review that policy change and explore potential statewide reforms to regulate these products.

The bill’s signing came after DeWine issued emergency regulations banning the sale of hemp products for 90 dayswith instructions to the legislature to consider permanent regulations. It has been done by a county judge ordered the state to enforce that policy in response to a legal challenge.


It’s Marijuana Time tracking hundreds of cannabis, psychedelic and drug policy bills in state legislatures and Congress this year. Patreon supporters by pledging at least $25/month, you’ll get access to our interactive maps, charts, and audio calendars so you never miss a development.


Learn more about our marijuana bill tracking and become a Patreon supporter to gain access

Meanwhile, in September, the Ohio Department of Cannabis Control (DCC) released rules for the state’s proposed marijuana legalization legislation, establishing plans to update regulations on labeling and packaging requirements.

Merchants of Ohio It sold more than $1 billion worth of legal marijuana products in 2025, according to data from the State Department of Commerce (DOC).

In March, a survey of 38 municipalities by the Ohio State University (OSU) Moritz School of Law found local leaders were “unequivocally opposed” to earlier proposals which would have cut planned funding..

Meanwhile, in Ohio, adults can buy more than double the amount of marijuana starting in June than were under previous limits, state officials determined that the market could sustainably supply patients and adult users of medical cannabis.

The governor announced his desire individually in March Marijuana tax revenue to support police training, local jails and behavioral health services. He said funding for police training was a top priority, even though it was not included when voters approved it in 2023.

Marijuana Moment is made possible with the help of readers. If you rely on our pro-cannabis journalism to stay informed, consider a monthly Patreon pledge.

Become a patron on Patreon!

Cannabis News

Massachusetts CCC pauses license applications

Published

on

By











The Cannabis Control Commission, the government body that oversees the marijuana business in the state of Massachusetts (USA), has decided to temporarily stop accepting new license applications for growing marijuana, both indoors and outdoors. This hiatus officially began on June 16, 2026.

Anyone planning to apply for a new marijuana cultivation license after June 16, 2026 will not be able to do so while this suspension is in effect. The Commission will not accept such requests during this period.

There are two groups that can continue normally. First, anyone who submitted an application before June 16, 2026, will continue to review and process applications as usual. Second, applicants for specific programs designed to help communities historically affected by drug laws, known as the Social Equity Program and the Economic Empowerment Program, are exempt from this suspension if they apply for a smaller-scale “Microenterprise” license.

The suspension will be in effect for 120 days from June 16, 2026, which is currently scheduled to be lifted around mid-October 2026. However, the Commission has the power to terminate earlier or extend further, depending on market conditions.

Source: Massachusetts Cannabis Control Commission










Continue Reading

Cannabis News

Federal Marijuana Rescheduling ‘Does Not Appear To Apply’ To Washington Businesses, State Officials Say

Published

on

By

Marijuana regulators in Washington say the Trump administration’s move to re-regulate cannabis at the federal level “doesn’t appear to apply” to the state’s businesses.

US Department of Justice in April He issued an order that immediately reclassified the state’s licensed medical cannabisas well as marijuana products approved by the Food and Drug Administration (FDA) under Schedule I through Schedule III of the Controlled Substances Act (CSA). A trial scheduled for this month will take place consider marijuana III.

“Washington does not issue licenses to producers, processors or retailers of medical cannabis,” the state’s Liquor and Cannabis Board (LCB) said in guidelines released Tuesday. “Instead, Washington has a single recreational market and within that market producers/processors can manufacture (DOH) compliant products, and certain retailers can sell DOH-compliant products to adult patients and all designated providers.”

“Therefore, Washington cannabis licensees do not appear to qualify as ‘state medical marijuana licensees’ and therefore may not be eligible for registration under the final Rule,” the agency said, referring to the Drug Enforcement Administration (DEA). Registration process for legal marijuana businesses in the state to take advantage of the federal benefits that come with the reform.

That said, the LCB “does not take a position if licensees decide to apply for federal registration,” the guidance continues. “If a licensee is seeking federal registration, we would be interested in learning about their experience and federal decisions.”

However, “based on our analysis, the federal reorganization in its current form does not appear to apply to cannabis licensees in Washington, primarily because of the legal framework governing recreational cannabis,” the LCB said.

The agency emphasized, however, that while it has consulted with the Cannabis Regulatory Association, the National Governors Association and industry stakeholders, its current opinion does not represent Washington’s formal opinion and “may not be our final interpretation as information is evolving and the decision may not rest with the state.”

“We await additional guidance from the federal agencies involved, new or updated federal agency processes and/or other federal procedures,” he said. he saidreferring to the next administrative hearing and Ongoing litigation calls into question the rescheduling of cannabis.

“The LCB recognizes that there are many cannabis growers, processors, and retailers actively involved in the production and sale of medical cannabis in Washington. These businesses may or may not be eligible to use the 280e tax deduction, and may also register with the DEA III. Ultimately, they have no input into whether their licensees meet the criteria for “state medical marijuana licensees,” as that determination can be made unilaterally by the DOJ within the meaning of the Final Rule. to reasonably interpret and determine that Washington cannabis licensees qualify as “state medical marijuana licensees.”

The US Treasury and Internal Revenue Service (IRS) said they plan to issued new tax guidelines for the marijuana industry after reprogramming. The reform will benefit state-licensed marijuana businesses by allowing them to take federal tax deductions that are currently prohibited under IRS Code Section III, known as Section 280E.

In California, regulators recently approved emergency rule changes to the state’s marijuana licensing process. to make it easier for companies to receive benefits In line with the Trump administration’s latest move to federally regulate medical cannabis.

Marijuana Moment is made possible with the help of readers. If you rely on our pro-cannabis journalism to stay informed, consider a monthly Patreon pledge.

Continue Reading

Cannabis News

How New Zealand showed up in London’s cannabis industry

Published

on

By

The medical cannabis market is expected to grow from $47 billion to $149 billion by 2031, and New Zealand has a real role to play in that story. And thanks in large part to New Zealand Trade and Enterprise (NZTE), the government’s international business development agency, Puro is starting to play.

At Cannabis Europa 2026 London, NZTE hosted an evening event at the City Arts Bar with Puro, New Zealand companies Bluelab, Rua Bioscience and CannFX. Puro called it The NZ Room.

Beyond all things Kiwiana – including Puro brand kiwifruit, Kiwi’d – the room was filled with some pretty amazing people: Ivy League scientists, company founders, patients, advocates, industry players, government officials, Maori tribal leaders and a tough Scotsman. All in the same space with the same true passion for where this industry is going.

It was one of those rooms where conversations went well when they had to end. That’s usually a sign of something well done.

Made possible by NZTE
For Puro, the NZTE relationship has been formative. With ongoing support, Puro has entered the Australian market with 47 unique product SKUs and signed a £7 million supply agreement with UK distributor IPS Pharma.

NZTE understands the potential of the New Zealand cannabis industry. The willingness to support this nascent industry and put New Zealand in the spotlight at events like Cannabis Europa is very significant. New Zealand is a small country and the country’s credibility in international markets is built from relationship to relationship, room by room. NZTE helps build those rooms.

© Cigar

what’s next
For the first time, patients in the UK have access to medicinal cannabis grown in New Zealand. That’s the direct result of years of work by Puro’s team, but it’s not worth much if you can’t connect with buyers globally. Creating international relationships that events like Cannabis Europa make this possible.

“We are grateful for the extensive support from the New Zealand Government that drives our progress, including the Ministry of Primary Industries’ support for our genetic breeding, product innovation and market access goals. This collective effort from agencies such as the Ministry of Business, Innovation and Employment, NZTE and the New Zealand Export Credit Bureau ensures that Mail that started in London will continue to grow in Puro’s international goals,” he said. a statement

For more information:
clean
www.puro.co.nz

Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media